Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Investigating the aetiology of adverse events following HPV vaccination with systems vaccinology.

Campbell-Tofte J, Vrahatis A, Josefsen K, Mehlsen J, Winther K.

Cell Mol Life Sci. 2019 Jan;76(1):67-87. doi: 10.1007/s00018-018-2925-6. Epub 2018 Oct 16. Review.

PMID:
30324425
2.

No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.

Schurink-Van't Klooster TM, Kemmeren JM, van der Maas NAT, van de Putte EM, Ter Wolbeek M, Nijhof SL, Vanrolleghem AM, van Vliet JA, Sturkenboom M, de Melker HE.

Vaccine. 2018 Oct 29;36(45):6796-6802. doi: 10.1016/j.vaccine.2018.09.019. Epub 2018 Sep 24.

3.

No conflicting results in the article "HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway".

Feiring B, Laake I, Trogstad L.

Vaccine. 2017 Dec 18;35(51):7082-7083. doi: 10.1016/j.vaccine.2017.09.041. No abstract available.

PMID:
29195611
4.

Conflicting results in article describing "HPV-vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis".

Andersson L.

Vaccine. 2017 Dec 18;35(51):7081. doi: 10.1016/j.vaccine.2017.09.042. No abstract available.

PMID:
29195610
5.

HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.

Feiring B, Laake I, Bakken IJ, Greve-Isdahl M, Wyller VB, HÃ¥berg SE, Magnus P, Trogstad L.

Vaccine. 2017 Jul 24;35(33):4203-4212. doi: 10.1016/j.vaccine.2017.06.031. Epub 2017 Jun 23.

Supplemental Content

Loading ...
Support Center